Papers
4
Total Citations
32
H-Index
3
About
Paul S. Freemont is a pioneering researcher at the intersection of synthetic biology, automated bioengineering, and biotechnology innovation. His work spans several transformative areas, including computer-aided genetic design, cell-free expression systems, and the development of automated biological platforms known as biofoundries. Freemont has made significant contributions to accelerating the design-build-test cycle in synthetic biology, most notably through the creation of software and robotic workcell platforms that enable rapid prototyping of genetic constructs in organisms such as *Saccharomyces cerevisiae* and *Bacillus megaterium*. His 2018 study on yeast genetic design automation garnered 18 citations, underscoring the community's recognition of this methodological advance. His work on cell-free transcription-translation systems, combined with Bayesian modelling, has opened new pathways for precisely characterizing genetic regulatory elements in non-standard microbial chassis. More recently, Freemont has extended his influence into global health policy, advocating for resilient biotechnology ecosystems capable of responding to future pandemics. His development of novel biosensors, including a curcumin-based direct protein detection system, further demonstrates his commitment to expanding the synthetic biology toolkit with practical, real-world applications.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4A curcumin direct protein biosensor for cell‐free prototyping3 citations · 2022